Abstract: System and method for managing spectral hole burning (SHB) effect in an optical transport network (OTN) link. The method is performed by an automatic gain control (AGC) circuit of an amplification assembly of the OTN link. The method comprises determining, via a first photodetector communicatively connected to the AGC circuit, an input power of an income signal and, in response to the input power being less than a predetermined portion of a full-loading signal power, causing a pump power variable attenuator (PVOA) of the amplification assembly to attenuate pump power from a pump source, the PVOA being disposed optically intermediate a first doped fiber and a second doped fiber of the amplification assembly.

Abstract: The invention discloses an engineered oncolytic respiratory syncytial virus (RSV), NS1 gene deficient RSV, and its usage to treat lung cancer by killing cancer cells with in vitro and in vivo evidences.

Abstract: The present invention is within the field of oncolytic virotherapy. Oncolytic virotherapy is a strategy using viruses, naturally occurring or genetically modified, to selectively target and destroy tumor cells while leaving surrounding non-malignant cells unharmed Here, an engineered respiratory syncytial virus (RSV), with the NS1 gene deleted (NS1 gene-deficient RSV, ?NS1 RSV), kills prostate cancer cells, but does not affect normal human cells.

Abstract: The invention discloses an engineered oncolytic respiratory syncytial virus (RSV), NS1 and NS2 gene deficient RSV (?NS1/NS2 RSV), and its usage to treat different types of human melanoma by killing cancer cells with in vitro evidences.

Abstract: The invention discloses an engineered oncolytic respiratory syncytial virus (RSV), NS1 gene deficient RSV, and its usage to treat breast cancer by killing cancer cells with in vitro and in vivo evidences.

Abstract: The invention discloses an engineered oncolytic respiratory syncytial virus (RSV), NS1 gene deficient RSV, and its usage to treat lung cancer by killing cancer cells with in vitro and in vivo evidences.

Abstract: This invention discloses a method by colored solution to prevent missing a solution in experiment.

Abstract: A magnetic logic element with toroidal magnetic multilayers (5,6,8,9). The magnetic logic element comprises a toroidal closed section which is fabricated by etching a unit of magnetic multilayers (5,6,8,9) deposited on a substrate. Optionally, the magnetic logic element may also comprise a metal core (10) in the closed toroidal section. Said magnetic multilayers (5,6,8,9) unit is arranged on the input signal lines A, B, C and an output signal line O, and then is made into a closed toroidal. Subsequently, on the toroidal magnetic multilayered unit (5,6,8,9), the input signal lines A?, B?, C? and an output signal line O? are fabricated by etching. This magnetic logic element can reduce the demagnetization field and the shape anisotropy effectively, leading to the decrease of the reversal field of magnetic free layer. Furthermore, this magnetic logic element has stable working performance and long operation life of the device.

Abstract: Each layer in the magnetic multilayer film is a closed ring or oval ring and the magnetic moment or flux of the ferromagnetic film in the magnetic unit is in close state either clockwise or counterclockwise. A metal core is put in the geometry center position in the close-shaped magnetic multilayer film. The cross section of the metal core is a corresponding circular or oval. A MRAM is made of the closed magnetic multilayer film with or without a metal core. The close-shaped magnetic multilayer film is formed by micro process method. The close-shaped magnetic multilayer film can be used broadly in a great variety of device that uses a magnetic multilayer film as the core, such as MRAM, magnetic bead in computer, magnetic sensitive sensor, magnetic logic device and spin transistor.

Abstract: A magnetic logic element with toroidal magnetic multilayers (5,6,8,9). The magnetic logic element comprises a toroidal closed section which is fabricated by etching a unit of magnetic multilayers (5,6,8,9) deposited on a substrate. Optionally, the magnetic logic element may also comprise a metal core (10) in the closed toroidal section. Said magnetic multilayers (5,6,8,9) unit is arranged on the input signal lines A, B, C and an output signal line O, and then is made into a closed toroidal. Subsequently, on the toroidal magnetic multilayered unit (5,6,8,9), the input signal lines A?, B?, C? and an output signal line O? are fabricated by etching. This magnetic logic element can reduce the demagnetization field and the shape anisotropy effectively, leading to the decrease of the reversal field of magnetic free layer. Furthermore, this magnetic logic element has stable working performance and long operation life of the device.

Abstract: Each layer in the magnetic multilayer film is a closed ring or oval ring and the magnetic moment or flux of the ferromagnetic film in the magnetic unit is in close state either clockwise or counterclockwise. A metal core is put in the geometry center position in the close-shaped magnetic multilayer film. The cross section of the metal core is a corresponding circular or oval. A MRAM is made of the closed magnetic multilayer film with or without a metal core. The close-shaped magnetic multilayer film is formed by micro process method. The close-shaped magnetic multilayer film can be used broadly in a great variety of device that uses a magnetic multilayer film as the core, such as MRAM, magnetic bead in computer, magnetic sensitive sensor, magnetic logic device and spin transistor.

Abstract: The present discloses a method to treat stroke, spinal cord injury, Parkinson disease, multiple sclerosis (MS), Parkinson disease, Amyotrophic Lateral Sclerosis (ALS), and other neurological as well as diabetes with bone marrow transplantation. The said bone marrow is transplanted as a whole, and does not need any cell isolation and cell expansion.

Abstract: The invention discloses a method of expansion and differentiation umbilical cord blood cells into neural-like cells in clinic grade, the cell preparation and herein the method for treating neurological condition in human.

Abstract: An online third party payment system is for business transaction, where the system functions as a guaranty between the seller and the buyer. The buyer pays money to the said system, and the money will not be released to any party until the business transaction is fulfilled. The said system guarantees the safety of the business transaction.

Abstract: A herbal formulation for prevention and/or treatment of flu. The formulations comprise of plant or plant extract together with vitamins and conventional additives. The plant is isatis indigotica, or strobilanthes cusia or the mixture thereof The formulations are in the form of tablet, powder, capsule, liquid or gum. Preferably, the formulations are in the manner of effervescent or chewing gum.